Literature DB >> 9371583

Mechanisms for virus-induced liver disease: tumor necrosis factor-mediated pathology independent of natural killer and T cells during murine cytomegalovirus infection.

J S Orange1, T P Salazar-Mather, S M Opal, C A Biron.   

Abstract

The contribution of endogenous NK cells and cytokines to virus-induced liver pathology was evaluated during murine cytomegalovirus infections of mice. In immunocompetent C57BL/6 mice, the virus induced a self-limited liver disease characterized by hepatitis, with focal inflammation, and large grossly visible subcapsular necrotic foci. The inflammatory foci were most numerous and contained the greatest number of cells 3 days after infection; they colocalized with areas of viral antigen expression. The largest number of necrotic foci was found 2 days after infection. Overall hepatic damage, assessed as increased expression of liver enzymes in serum, accompanied the development of inflammatory and necrotic foci. Experiments with neutralizing antibodies demonstrated that although virus-induced tumor necrosis factor (TNF) can have antiviral effects, it also mediated significant liver pathology. TNF was required for development of hepatic necrotic foci and increased levels of liver enzymes in serum but not for increased numbers of inflammatory foci. The necrotic foci and liver enzyme indications of pathology occurred independently of NK and T cells, because mice rendered NK-cell deficient by treatment with antibodies, T- and B-cell-deficient Rag-/- mice, and NK- and T-cell-deficient E26 mice all manifested both parameters of disease. Development of necrotic foci and maximally increased levels of liver enzymes in serum also were TNF dependent in NK-cell-deficient mice. Moreover, in the immunodeficient E26 mice, virus-induced liver disease was progressive, with eventual death of the host, and neutralization of TNF significantly increased longevity. These results establish conditions separating hepatitis from significant liver damage and demonstrate a cytokine-mediated component to viral pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371583      PMCID: PMC230227     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Cytomegalovirus hepatitis in liver transplantation: prospective analysis of 93 consecutive orthotopic liver transplantations.

Authors:  C V Paya; P E Hermans; R H Wiesner; J Ludwig; T F Smith; J Rakela; R A Krom
Journal:  J Infect Dis       Date:  1989-11       Impact factor: 5.226

Review 2.  Cytomegalovirus.

Authors:  M A Smith; D J Brennessel
Journal:  Infect Dis Clin North Am       Date:  1994-06       Impact factor: 5.982

3.  Infection of a macrophage-like cell line, P388D1 with reovirus; effects of immune ascitic fluids and monoclonal antibodies on neutralization and on enhancement of viral growth.

Authors:  S J Burstin; M W Brandriss; J J Schlesinger
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

4.  Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. II. Pathogenesis.

Authors:  R O Jacoby; P N Bhatt
Journal:  Lab Anim Sci       Date:  1987-02

5.  Cytokine toxicity and induction of NO synthase activity in cultured mouse hepatocytes.

Authors:  G M Adamson; R E Billings
Journal:  Toxicol Appl Pharmacol       Date:  1993-03       Impact factor: 4.219

6.  Increased susceptibility to cytomegalovirus infection in beige mutant mice.

Authors:  G R Shellam; J E Allan; J M Papadimitriou; G J Bancroft
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

7.  Characterization of early cytokine responses and an interleukin (IL)-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection.

Authors:  M C Ruzek; A H Miller; S M Opal; B D Pearce; C A Biron
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

8.  Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function.

Authors:  R M Welsh; J O Brubaker; M Vargas-Cortes; C L O'Donnell
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

9.  Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis.

Authors:  K Ando; T Moriyama; L G Guidotti; S Wirth; R D Schreiber; H J Schlicht; S N Huang; F V Chisari
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

10.  Acute and chronic changes in the microcirculation of the liver in inbred strains of mice following infection with mouse hepatitis virus type 3.

Authors:  P J MacPhee; V J Dindzans; L S Fung; G A Levy
Journal:  Hepatology       Date:  1985 Jul-Aug       Impact factor: 17.425

View more
  30 in total

Review 1.  Immunoregulatory cytokine networks: 60 years of learning from murine cytomegalovirus.

Authors:  Christine A Biron; Margarite L Tarrio
Journal:  Med Microbiol Immunol       Date:  2015-04-08       Impact factor: 3.402

2.  Transmission of murine cytomegalovirus in breast milk: a model of natural infection in neonates.

Authors:  Carol A Wu; Sara A Paveglio; Elizabeth G Lingenheld; Li Zhu; Leo Lefrançois; Lynn Puddington
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

Review 3.  Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection.

Authors:  Marni N Silverman; Brad D Pearce; Christine A Biron; Andrew H Miller
Journal:  Viral Immunol       Date:  2005       Impact factor: 2.257

4.  Antiviral T cell response triggers cytomegalovirus hepatitis in mice.

Authors:  Devon Livingston-Rosanoff; Lisa P Daley-Bauer; AnaPatricia Garcia; A Louise McCormick; Jing Huang; Edward S Mocarski
Journal:  J Virol       Date:  2012-09-19       Impact factor: 5.103

5.  Infection of neonatal mice with sindbis virus results in a systemic inflammatory response syndrome.

Authors:  W B Klimstra; K D Ryman; K A Bernard; K B Nguyen; C A Biron; R E Johnston
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  Hepatic DR5 induces apoptosis and limits adenovirus gene therapy product expression in the liver.

Authors:  Huang-Ge Zhang; Jinfu Xie; Liang Xu; Pingar Yang; Xin Xu; Sheher Sun; Yongming Wang; David T Curiel; Hui-Chen Hsu; John D Mountz
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

7.  Role of NF-kappaB and myc proteins in apoptosis induced by hepatitis B virus HBx protein.

Authors:  F Su; C N Theodosis; R J Schneider
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

8.  Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus.

Authors:  Julia Diegelmann; Florian Beigel; Kathrin Zitzmann; Artur Kaul; Burkhard Göke; Christoph J Auernhammer; Ralf Bartenschlager; Helmut M Diepolder; Stephan Brand
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240

9.  Dominant-negative FADD rescues the in vivo fitness of a cytomegalovirus lacking an antiapoptotic viral gene.

Authors:  Luka Cicin-Sain; Zsolt Ruzsics; Juergen Podlech; Ivan Bubić; Carine Menard; Stipan Jonjić; Matthias J Reddehase; Ulrich H Koszinowski
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

10.  Cytomegalovirus M45 cell death suppression requires receptor-interacting protein (RIP) homotypic interaction motif (RHIM)-dependent interaction with RIP1.

Authors:  Jason W Upton; William J Kaiser; Edward S Mocarski
Journal:  J Biol Chem       Date:  2008-04-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.